Catalyst Intel Subscribe

Trial results

$FDMT — 4D-150

4D Molecular Therapeutics, Inc. (FDMT) 4D-150: trial results in wet AMD, 2027.

Research by Catalyst Intel

The catalyst

"We anticipate topline data for 4FRONT-1 in the second quarter of 2027."

— 4D Molecular Therapeutics, 10-Q filed 2026-11-12 · the filing. Checked word for word against the stored document when this page was built; a sentence that did not check out would not be here.

Event id
FDMT-4D150-2026
Company
4D Molecular Therapeutics, Inc.
Kind
Trial results
Indication
wet AMD
Window
2027-01-01 – 2027-12-31
Status
dropped

The bar

No bar has been published for this event yet.

Verdicts

No verdict has been published for this event yet.